Рецептор, активируемый пероксисомным пролифератором дельта (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Рецептор, активируемый пероксисомным пролифератором дельта" in Russian language version.

refsWebsite

Global rank Russian rank

35nih.gov

4^th place

6^th place

21doi.org

2^nd place

3^rd place

5semanticscholar.org

11^th place

286^th place

4web.archive.org

1^st place

2ensembl.org

1,626^th place

1,163^rd place

2harvard.edu

18^th place

63^rd place

1uniprot.org

5,673^rd place

8,450^th place

1theconversation.com

928^th place

1,518^th place

doi.org

Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (October 1992). "Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids". Molecular Endocrinology. 6 (10): 1634—1641. doi:10.1210/mend.6.10.1333051. PMID 1333051. S2CID 23506853.
Krey G, Keller H, Mahfoudi A, Medin J, Ozato K, Dreyer C, Wahli W (December 1993). "Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids". The Journal of Steroid Biochemistry and Molecular Biology. 47 (1—6): 65—73. doi:10.1016/0960-0760(93)90058-5. PMID 8274443. S2CID 25098754.
Berger J, Moller DE (2002). "The mechanisms of action of PPARs". Annual Review of Medicine. 53: 409—435. doi:10.1146/annurev.med.53.082901.104018. PMID 11818483.
Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W (March 2006). "From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions". Progress in Lipid Research. 45 (2): 120—159. doi:10.1016/j.plipres.2005.12.002. PMID 16476485.
Giordano Attianese GM, Desvergne B (2015). "Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function". Nuclear Receptor Signaling. 13: e001. doi:10.1621/nrs.13001. PMC 4419664. PMID 25945080.
Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, et al. (August 2008). "AMPK and PPARdelta agonists are exercise mimetics". Cell. 134 (3): 405—415. doi:10.1016/j.cell.2008.06.051. PMC 2706130. PMID 18674809.
Takayama O, Yamamoto H, Damdinsuren B, Sugita Y, Ngan CY, Xu X, et al. (October 2006). "Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology". British Journal of Cancer. 95 (7): 889—895. doi:10.1038/sj.bjc.6603343. PMC 2360534. PMID 16969348.
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. (February 2006). "PPARdelta regulates glucose metabolism and insulin sensitivity". Proceedings of the National Academy of Sciences of the United States of America. 103 (9): 3444—3449. Bibcode:2006PNAS..103.3444L. doi:10.1073/pnas.0511253103. PMC 1413918. PMID 16492734.
Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S, et al. (April 2004). "Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes". The Journal of Investigative Dermatology. 122 (4): 971—983. doi:10.1111/j.0022-202X.2004.22412.x. PMID 15102088.
Tan NS, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, Michalik L (October 2007). "The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration". Molecular and Cellular Biology. 27 (20): 7161—7175. doi:10.1128/MCB.00436-07. PMC 2168901. PMID 17682064.
Wagner N, Wagner KD (May 2020). "PPAR Beta/Delta and the Hallmarks of Cancer". Cells. 9 (5): 1133. doi:10.3390/cells9051133. PMC 7291220. PMID 32375405.
Wagner KD, Du S, Martin L, Leccia N, Michiels JF, Wagner N (December 2019). "Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression". Cells. 8 (12): 1623. doi:10.3390/cells8121623. PMC 6952835. PMID 31842402.
Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM (July 2008). "Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice". Biochemical and Biophysical Research Communications. 371 (3): 456—461. doi:10.1016/j.bbrc.2008.04.086. PMC 2586836. PMID 18442472.
Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, et al. (July 2000). "Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)". Molecular and Cellular Biology. 20 (14): 5119—5128. doi:10.1128/MCB.20.14.5119-5128.2000. PMC 85961. PMID 10866668.
Brunmair B, Staniek K, Dörig J, Szöcs Z, Stadlbauer K, Marian V, et al. (November 2006). "Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids". Diabetologia. 49 (11): 2713—2722. doi:10.1007/s00125-006-0357-6. PMID 16960684.
van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, et al. (March 2005). "Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1" (PDF). Journal of Lipid Research. 46 (3): 526—534. doi:10.1194/jlr.M400400-JLR200. PMID 15604518. Архивировано (PDF) 8 марта 2019. Дата обращения: 12 декабря 2023.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, et al. (August 2023). "Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study". Hepatology. 78 (2): 397—415. doi:10.1097/HEP.0000000000000395. PMC 10344437. PMID 37386786.
Trevisiol S, Moulard Y, Delcourt V, Jaubert M, Boyer S, Tendon S, et al. (June 2021). "Comprehensive characterization of the peroxisome proliferator activated receptor-δ agonist GW501516 for horse doping control analysis". Drug Testing and Analysis. 13 (6): 1191—1202. doi:10.1002/dta.3013. PMID 33547737. S2CID 231899376.
Sobolevsky T, Dikunets M, Sukhanova I, Virus E, Rodchenkov G (October 2012). "Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine". Drug Testing and Analysis. 4 (10): 754—760. doi:10.1002/dta.1413. PMID 22977012.
Franco PJ, Li G, Wei LN (August 2003). "Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase". Molecular and Cellular Endocrinology. 206 (1—2): 1—12. doi:10.1016/S0303-7207(03)00254-5. PMID 12943985. S2CID 19487189.
Shi Y, Hon M, Evans RM (March 2002). "The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling". Proceedings of the National Academy of Sciences of the United States of America. 99 (5): 2613—2618. Bibcode:2002PNAS...99.2613S. doi:10.1073/pnas.052707099. PMC 122396. PMID 11867749.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000112033 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000002250 - Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. (February 2006). "PPARdelta regulates glucose metabolism and insulin sensitivity". Proceedings of the National Academy of Sciences of the United States of America. 103 (9): 3444—3449. Bibcode:2006PNAS..103.3444L. doi:10.1073/pnas.0511253103. PMC 1413918. PMID 16492734.
Shi Y, Hon M, Evans RM (March 2002). "The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling". Proceedings of the National Academy of Sciences of the United States of America. 99 (5): 2613—2618. Bibcode:2002PNAS...99.2613S. doi:10.1073/pnas.052707099. PMC 122396. PMID 11867749.

nih.gov

pubmed.ncbi.nlm.nih.gov

Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (October 1992). "Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids". Molecular Endocrinology. 6 (10): 1634—1641. doi:10.1210/mend.6.10.1333051. PMID 1333051. S2CID 23506853.
Krey G, Keller H, Mahfoudi A, Medin J, Ozato K, Dreyer C, Wahli W (December 1993). "Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids". The Journal of Steroid Biochemistry and Molecular Biology. 47 (1—6): 65—73. doi:10.1016/0960-0760(93)90058-5. PMID 8274443. S2CID 25098754.
Berger J, Moller DE (2002). "The mechanisms of action of PPARs". Annual Review of Medicine. 53: 409—435. doi:10.1146/annurev.med.53.082901.104018. PMID 11818483.
Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W (March 2006). "From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions". Progress in Lipid Research. 45 (2): 120—159. doi:10.1016/j.plipres.2005.12.002. PMID 16476485.
Giordano Attianese GM, Desvergne B (2015). "Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function". Nuclear Receptor Signaling. 13: e001. doi:10.1621/nrs.13001. PMC 4419664. PMID 25945080.
Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, et al. (August 2008). "AMPK and PPARdelta agonists are exercise mimetics". Cell. 134 (3): 405—415. doi:10.1016/j.cell.2008.06.051. PMC 2706130. PMID 18674809.
Takayama O, Yamamoto H, Damdinsuren B, Sugita Y, Ngan CY, Xu X, et al. (October 2006). "Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology". British Journal of Cancer. 95 (7): 889—895. doi:10.1038/sj.bjc.6603343. PMC 2360534. PMID 16969348.
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. (February 2006). "PPARdelta regulates glucose metabolism and insulin sensitivity". Proceedings of the National Academy of Sciences of the United States of America. 103 (9): 3444—3449. Bibcode:2006PNAS..103.3444L. doi:10.1073/pnas.0511253103. PMC 1413918. PMID 16492734.
Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S, et al. (April 2004). "Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes". The Journal of Investigative Dermatology. 122 (4): 971—983. doi:10.1111/j.0022-202X.2004.22412.x. PMID 15102088.
Tan NS, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, Michalik L (October 2007). "The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration". Molecular and Cellular Biology. 27 (20): 7161—7175. doi:10.1128/MCB.00436-07. PMC 2168901. PMID 17682064.
Wagner N, Wagner KD (May 2020). "PPAR Beta/Delta and the Hallmarks of Cancer". Cells. 9 (5): 1133. doi:10.3390/cells9051133. PMC 7291220. PMID 32375405.
Wagner KD, Du S, Martin L, Leccia N, Michiels JF, Wagner N (December 2019). "Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression". Cells. 8 (12): 1623. doi:10.3390/cells8121623. PMC 6952835. PMID 31842402.
Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM (July 2008). "Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice". Biochemical and Biophysical Research Communications. 371 (3): 456—461. doi:10.1016/j.bbrc.2008.04.086. PMC 2586836. PMID 18442472.
Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, et al. (July 2000). "Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)". Molecular and Cellular Biology. 20 (14): 5119—5128. doi:10.1128/MCB.20.14.5119-5128.2000. PMC 85961. PMID 10866668.
Brunmair B, Staniek K, Dörig J, Szöcs Z, Stadlbauer K, Marian V, et al. (November 2006). "Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids". Diabetologia. 49 (11): 2713—2722. doi:10.1007/s00125-006-0357-6. PMID 16960684.
van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, et al. (March 2005). "Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1" (PDF). Journal of Lipid Research. 46 (3): 526—534. doi:10.1194/jlr.M400400-JLR200. PMID 15604518. Архивировано (PDF) 8 марта 2019. Дата обращения: 12 декабря 2023.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, et al. (August 2023). "Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study". Hepatology. 78 (2): 397—415. doi:10.1097/HEP.0000000000000395. PMC 10344437. PMID 37386786.
Trevisiol S, Moulard Y, Delcourt V, Jaubert M, Boyer S, Tendon S, et al. (June 2021). "Comprehensive characterization of the peroxisome proliferator activated receptor-δ agonist GW501516 for horse doping control analysis". Drug Testing and Analysis. 13 (6): 1191—1202. doi:10.1002/dta.3013. PMID 33547737. S2CID 231899376.
Sobolevsky T, Dikunets M, Sukhanova I, Virus E, Rodchenkov G (October 2012). "Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine". Drug Testing and Analysis. 4 (10): 754—760. doi:10.1002/dta.1413. PMID 22977012.
Franco PJ, Li G, Wei LN (August 2003). "Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase". Molecular and Cellular Endocrinology. 206 (1—2): 1—12. doi:10.1016/S0303-7207(03)00254-5. PMID 12943985. S2CID 19487189.
Shi Y, Hon M, Evans RM (March 2002). "The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling". Proceedings of the National Academy of Sciences of the United States of America. 99 (5): 2613—2618. Bibcode:2002PNAS...99.2613S. doi:10.1073/pnas.052707099. PMC 122396. PMID 11867749.

ncbi.nlm.nih.gov

Ссылка на публикацию человека на PubMed: (неопр.) Национальный центр биотехнологической информации, Национальная медицинская библиотека США.
Ссылка на публикацию мыши на PubMed: (неопр.) Национальный центр биотехнологической информации, Национальная медицинская библиотека США.
Giordano Attianese GM, Desvergne B (2015). "Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function". Nuclear Receptor Signaling. 13: e001. doi:10.1621/nrs.13001. PMC 4419664. PMID 25945080.
Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, et al. (August 2008). "AMPK and PPARdelta agonists are exercise mimetics". Cell. 134 (3): 405—415. doi:10.1016/j.cell.2008.06.051. PMC 2706130. PMID 18674809.
Takayama O, Yamamoto H, Damdinsuren B, Sugita Y, Ngan CY, Xu X, et al. (October 2006). "Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology". British Journal of Cancer. 95 (7): 889—895. doi:10.1038/sj.bjc.6603343. PMC 2360534. PMID 16969348.
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. (February 2006). "PPARdelta regulates glucose metabolism and insulin sensitivity". Proceedings of the National Academy of Sciences of the United States of America. 103 (9): 3444—3449. Bibcode:2006PNAS..103.3444L. doi:10.1073/pnas.0511253103. PMC 1413918. PMID 16492734.
Entrez Gene: PPARD peroxisome proliferator-activated receptor delta (неопр.). Дата обращения: 12 декабря 2023. Архивировано 3 июня 2020 года.
Tan NS, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, Michalik L (October 2007). "The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration". Molecular and Cellular Biology. 27 (20): 7161—7175. doi:10.1128/MCB.00436-07. PMC 2168901. PMID 17682064.
Wagner N, Wagner KD (May 2020). "PPAR Beta/Delta and the Hallmarks of Cancer". Cells. 9 (5): 1133. doi:10.3390/cells9051133. PMC 7291220. PMID 32375405.
Wagner KD, Du S, Martin L, Leccia N, Michiels JF, Wagner N (December 2019). "Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression". Cells. 8 (12): 1623. doi:10.3390/cells8121623. PMC 6952835. PMID 31842402.
Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM (July 2008). "Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice". Biochemical and Biophysical Research Communications. 371 (3): 456—461. doi:10.1016/j.bbrc.2008.04.086. PMC 2586836. PMID 18442472.
Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, et al. (July 2000). "Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)". Molecular and Cellular Biology. 20 (14): 5119—5128. doi:10.1128/MCB.20.14.5119-5128.2000. PMC 85961. PMID 10866668.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, et al. (August 2023). "Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study". Hepatology. 78 (2): 397—415. doi:10.1097/HEP.0000000000000395. PMC 10344437. PMID 37386786.
Shi Y, Hon M, Evans RM (March 2002). "The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling". Proceedings of the National Academy of Sciences of the United States of America. 99 (5): 2613—2618. Bibcode:2002PNAS...99.2613S. doi:10.1073/pnas.052707099. PMC 122396. PMID 11867749.

semanticscholar.org

api.semanticscholar.org

Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (October 1992). "Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids". Molecular Endocrinology. 6 (10): 1634—1641. doi:10.1210/mend.6.10.1333051. PMID 1333051. S2CID 23506853.
Krey G, Keller H, Mahfoudi A, Medin J, Ozato K, Dreyer C, Wahli W (December 1993). "Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids". The Journal of Steroid Biochemistry and Molecular Biology. 47 (1—6): 65—73. doi:10.1016/0960-0760(93)90058-5. PMID 8274443. S2CID 25098754.
Trevisiol S, Moulard Y, Delcourt V, Jaubert M, Boyer S, Tendon S, et al. (June 2021). "Comprehensive characterization of the peroxisome proliferator activated receptor-δ agonist GW501516 for horse doping control analysis". Drug Testing and Analysis. 13 (6): 1191—1202. doi:10.1002/dta.3013. PMID 33547737. S2CID 231899376.
Franco PJ, Li G, Wei LN (August 2003). "Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase". Molecular and Cellular Endocrinology. 206 (1—2): 1—12. doi:10.1016/S0303-7207(03)00254-5. PMID 12943985. S2CID 19487189.

pdfs.semanticscholar.org

van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, et al. (March 2005). "Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1" (PDF). Journal of Lipid Research. 46 (3): 526—534. doi:10.1194/jlr.M400400-JLR200. PMID 15604518. Архивировано (PDF) 8 марта 2019. Дата обращения: 12 декабря 2023.

theconversation.com

Koh B (22 March 2013). "Anti-doping agency warns cheats on the health risks of Endurobol". The Conversation (англ.). Архивировано 4 сентября 2023. Дата обращения: 5 сентября 2023.

uniprot.org

UniProt, Q03181 (англ.). Дата обращения: 12 декабря 2023. Архивировано 12 декабря 2023 года.

web.archive.org

UniProt, Q03181 (англ.). Дата обращения: 12 декабря 2023. Архивировано 12 декабря 2023 года.
Entrez Gene: PPARD peroxisome proliferator-activated receptor delta (неопр.). Дата обращения: 12 декабря 2023. Архивировано 3 июня 2020 года.
van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, et al. (March 2005). "Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1" (PDF). Journal of Lipid Research. 46 (3): 526—534. doi:10.1194/jlr.M400400-JLR200. PMID 15604518. Архивировано (PDF) 8 марта 2019. Дата обращения: 12 декабря 2023.
Koh B (22 March 2013). "Anti-doping agency warns cheats on the health risks of Endurobol". The Conversation (англ.). Архивировано 4 сентября 2023. Дата обращения: 5 сентября 2023.